 RAMSEY, N.J. and BOCA RATON, Fla., Oct. 04, 2021 GLOBE NEWSWIRE -- ADMA Biologics, Inc. Nasdaq: ADMA ADMA or the Company, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced on-demand access to an exclusive educational event at IDWeek 2021 on respiratory viral infections, presented by nationally recognized clinical experts Dr. Michael Ison from Northwestern University and Dr. Jolan Walter from the University of South Florida and Johns Hopkins All Childrens Hospital. During the live presentation and question and answer session, Dr. Walter discussed real-world experiences in patients that were successfully treated with ADMAs ASCENIVTM, a novel intravenous immunoglobulin IVIG product with a unique composition. The two cases presented detailed scenarios in which ASCENIV administration demonstrated notable benefits in the clinical course of two children diagnosed with primary immunodeficiency PI and documented RSV infection. 